Sg Americas Securities, LLC Rigel Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$1.12 - $1.57 $30,782 - $43,149	-27,484 Reduced 55.33%	22,189 $33,000
Q4 2023 Jan 12, 2024	BUY	$0.72 - $1.56 $13,089 - $28,360	18,180 Added 57.73%	49,673 $72,000
Q3 2023 Oct 13, 2023	BUY	$1.07 - $1.39 $33,697 - $43,775	31,493 New	31,493 $34,000
Q1 2023 Apr 28, 2023	BUY	$1.25 - $2.0 $187,213 - $299,542	149,771 New	149,771 $198,000
Q3 2022 Oct 31, 2022	SELL	$1.1 - $12.2 $105,767 - $1.17 Million	-96,152 Reduced 48.51%	102,058 $120,000
Q2 2022 Jul 29, 2022	BUY	$0.67 - $3.19 $132,800 - $632,289	198,210 New	198,210 $224,000
Q1 2022 Apr 29, 2022	SELL	$2.22 - $3.45 $65,061 - $101,109	-29,307 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$2.36 - $3.57 $125,004 - $189,095	-52,968 Reduced 64.38%	29,307 $78,000
Q3 2021 Nov 01, 2021	BUY	$3.5 - $4.5 $243,316 - $312,835	69,519 Added 544.99%	82,275 $299,000
Q2 2021 Aug 12, 2021	SELL	$3.09 - $4.54 $77,416 - $113,745	-25,054 Reduced 66.26%	12,756 $55,000
Q1 2021 May 13, 2021	SELL	$3.35 - $4.93 $1.34 Million - $1.97 Million	-398,640 Reduced 91.34%	37,810 $129,000
Q4 2020 Feb 04, 2021	BUY	$2.35 - $3.74 $845,696 - $1.35 Million	359,871 Added 469.93%	436,450 $1.53 Million
Q3 2020 Nov 09, 2020	BUY	$1.78 - $4.13 $115,794 - $268,668	65,053 Added 564.4%	76,579 $184,000
Q2 2020 Jul 20, 2020	SELL	$1.41 - $2.05 $182,790 - $265,759	-129,639 Reduced 91.84%	11,526 $21,000
Q1 2020 Apr 30, 2020	BUY	$1.27 - $3.0 $151,268 - $357,327	119,109 Added 540.03%	141,165 $220,000
Q4 2019 Jan 28, 2020	BUY	$1.6 - $2.43 $3,033 - $4,607	1,896 Added 9.4%	22,056 $47,000
Q3 2019 Nov 04, 2019	BUY	$1.63 - $2.62 $32,860 - $52,819	20,160 New	20,160 $38,000
Q2 2019 Jul 29, 2019	SELL	$2.02 - $2.61 $43,393 - $56,068	-21,482 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$2.0 - $2.65 $42,964 - $56,927	21,482 New	21,482 $55,000
Q3 2018 Nov 06, 2018	SELL	$2.6 - $3.59 $81,281 - $112,230	-31,262 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$2.83 - $4.11 $39,263 - $57,022	13,874 Added 79.79%	31,262 $88,000
Q1 2018 May 03, 2018	BUY	$3.54 - $4.54 $10,991 - $14,096	3,105 Added 21.74%	17,388 $62,000
Q4 2017 Jan 24, 2018	SELL	$3.23 - $4.3 $145,731 - $194,007	-45,118 Reduced 75.95%	14,283 $55,000
Q3 2017 Nov 07, 2017	BUY	$2.18 - $2.57 $129,494 - $152,660	59,401	59,401 $151,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account